Opportunities and Challenges of Using Big Data to Detect Drug‐Drug Interaction Risk-Reference-Cited by-同舟云学术

Opportunities and Challenges of Using Big Data to Detect Drug‐Drug Interaction Risk

Published:2019-06-11 Issue:1 Volume:106 Page:72-74
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Quinney Sara K.¹

Affiliation:

1. Department of Obstetrics and Gynecology and Division of Clinical PharmacologyDepartment of MedicineIndiana University School of MedicineSchool of Informatics and ComputingIndiana University Purdue University Indianapolis Indianapolis Indiana USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1481

Reference9 articles.

1. Adverse drug events in the outpatient setting: an 11-year national analysis

2. Translational Biomedical Informatics and Pharmacometrics Approaches in the Drug Interactions Research

3. Detection of drug–drug interactions through data mining studies using clinical sources, scientific literature and social media

4. Data mining for signals in spontaneous reporting databases: proceed with caution

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DrugMAP 2.0: molecular atlas and pharma-information of all drugs;Nucleic Acids Research;2024-09-13

2. Identifying Drug–Drug Interactions in Spontaneous Reports Utilizing Signal Detection and Biological Plausibility Aspects;Clinical Pharmacology & Therapeutics;2024-04-08

3. Response to the comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions;Pharmacoepidemiology and Drug Safety;2023-11-27

4. Identifying drug-drug interactions in spontaneous reports utilizing signal detection and biological plausibility aspects;2023-10-26

5. DrugMAP: molecular atlas and pharma-information of all drugs;Nucleic Acids Research;2022-10-16